T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Elevance Health
ELV
$86.2B
| $3.8B | 0.62% |
16,869,167
+2,419,549
| +17% | +$515M |
|
|
27
PayPal
PYPL
$50.5B
| $3.73B | 0.61% |
50,698,914
-22,924,565
| -31% | -$1.66B |
|
28
Cigna
CI
$73.6B
| $3.61B | 0.59% |
17,756,569
+668,042
| +4% | +$133M |
|
|
AMTD
29
DELISTED
TD Ameritrade Holding Corp
AMTD
| $3.58B | 0.58% |
69,992,704
+1,821,227
| +3% | +$91M |
|
30
American Airlines Group
AAL
$9.93B
| $3.56B | 0.58% |
68,414,157
-2,743,972
| -4% | -$137M |
|
31
Tyson Foods
TSN
$20.1B
| $3.37B | 0.55% |
41,517,291
+3,266,040
| +9% | +$250M |
|
|
32
Tesla
TSLA
$1.31T
| $3.36B | 0.55% |
161,872,380
+85,704,030
| +113% | +$1.86B |
|
33
Crown Castle
CCI
$31.3B
| $3.09B | 0.5% |
27,816,968
-1,035,425
| -4% | -$112M |
|
34
Netflix
NFLX
$318B
| $3.09B | 0.5% |
160,797,640
+21,209,370
| +15% | +$408M |
|
35
Merck
MRK
$323B
| $3.05B | 0.5% |
56,845,297
-4,824,750
| -8% | -$267M |
|
|
36
Broadcom
AVGO
$2.01T
| $3B | 0.49% |
116,840,170
+49,673,370
| +74% | +$1.29B |
|
|
AET
37
DELISTED
Aetna Inc
AET
| $2.98B | 0.48% |
16,511,568
-4,801,669
| -23% | -$825M |
|
38
ExxonMobil
XOM
$662B
| $2.92B | 0.47% |
34,968,709
-2,324,720
| -6% | -$192M |
|
39
Intercontinental Exchange
ICE
$84.5B
| $2.9B | 0.47% |
41,087,599
-27,662
| -0.1% | -$1.9M |
|
|
MRSH
40
Marsh
MRSH
$91B
| $2.88B | 0.47% |
35,436,235
+570,344
| +2% | +$47.4M |
|
41
Citigroup
C
$227B
| $2.83B | 0.46% |
38,049,306
-3,058,287
| -7% | -$226M |
|
42
Dollar General
DG
$27B
| $2.74B | 0.44% |
29,470,681
+2,843,814
| +11% | +$244M |
|
43
Biogen
BIIB
$30.6B
| $2.72B | 0.44% |
8,534,311
-2,147,067
| -20% | -$689M |
|
44
Yum! Brands
YUM
$39.7B
| $2.7B | 0.44% |
33,033,765
-921,168
| -3% | -$72.9M |
|
45
Johnson & Johnson
JNJ
$631B
| $2.69B | 0.44% |
19,280,931
+221,038
| +1% | +$30.8M |
|
46
State Street
STT
$51.3B
| $2.67B | 0.43% |
27,388,222
-4,300,830
| -14% | -$411M |
|
47
Fortive
FTV
$18.6B
| $2.65B | 0.43% |
58,161,780
+6,558,857
| +13% | +$300M |
|
48
Honeywell
HON
$77B
| $2.61B | 0.42% |
18,816,588
+235,709
| +1% | +$31.6M |
|
|
RHT
49
DELISTED
Red Hat Inc
RHT
| $2.58B | 0.42% |
21,489,796
+1,734,854
| +9% | +$213M |
|
50
Verizon
VZ
$195B
| $2.58B | 0.42% |
48,674,620
+11,355,788
| +30% | +$558M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.